Xtandi 40-IND (Enzalutamide Capsule) 40mg

Xtandi 40-IND (Enzalutamide 40mg capsules) is a prescription medication used for prostate cancer treatment. This 112-count pack offers a convenient supply for ongoing therapy. Keep capsules below 25°C for proper storage. Consult your healthcare provider for suitability.

Strength

40mg

Pack Size

112s

Storage

Below 25°C

Manufacturer / TM Owner

Catalent pharma Solutions LLC For Astellas Pharma US

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Enzalutamide 40mg capsules are primarily used to treat prostate cancer in adults. This medication works by blocking hormones that fuel cancer growth. It may be prescribed for metastatic or non-metastatic cases depending on medical assessment. Patients often use it alongside other prostate cancer treatments. Always follow your doctor's specific guidance for your condition.

Side Effects

Many patients report reduced cancer-related symptoms while taking enzalutamide. Common effects include fatigue, back pain, and hot flashes. Some experience digestive changes or joint discomfort. These effects vary widely between individuals. Most symptoms are manageable with medical supervision.

Precautions & Warnings

Store enzalutamide capsules below 25°C in their original container. Keep out of reach of children and pets. Handle with care to avoid capsule damage. Do not use if the packaging appears damaged or tampered with. Report any unusual symptoms to your healthcare provider promptly.

Avoid Interactions

Enzalutamide may interact with certain medications, including blood thinners and seizure drugs. Avoid grapefruit products while taking this medication. Some herbal supplements may also affect how enzalutamide works. Always inform your doctor about all medications you're currently taking. Alcohol consumption may intensify certain side effects.

References

Frequently Asked Questions

Enzalutamide 40mg capsules are used to treat prostate cancer in adults by blocking hormones that promote cancer growth.

Store enzalutamide capsules below 25°C in their original container, away from moisture and direct light.

Consult your healthcare provider before combining enzalutamide with any other medications or supplements.

Common effects may include fatigue, back pain, hot flashes, and digestive changes.

No, enzalutamide requires a prescription from a licensed healthcare provider.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.